St Baldrick's Foundation Inc

What it reported doing in 2024

The st. Baldrick's foundation is the largest non-government funder of childhood cancer research grants in the u.s. These grants support every stage of research, from new discoveries to clinical trials, as well as the training of the next generation of pediatric oncology researchers. The foundation also advocates for more effective policies and increased federal funding for childhood cancer research. (continued on schedule o.)the foundation makes disease-specific grants as well as grants aimed at multiple childhood cancers. In fy 2025, grants included the following categories: research grants -- 2-year hypothesis-driven research projects. Strategic research partnership grants awards -- large 3-year grants chosen via scientific review of applications solicited specifically for disease-specific research funded by donors and charity partners.fellowships -- early career researchers completing their pediatric oncology research training.scholars -- young investigator awards to enable early career scientists to continue research. International scholars -- training for researchers from low- and middle-income countries, to then return and conduct research in their home country. Infrastructure grants -- support to open and conduct more clinical trials, to give children access to life-saving treatments closer to home.children's oncology group -- support disbursed to more than 200 institutions across north america and beyond, for the treatment of children on cog clinical trials.st. Baldrick's epicc team (empowering pediatric immunotherapies for childhood cancers) -- research to develop new immunotherapies for multiple childhood cancer types.international beneficiaries -- support for research in other countries where st. Baldrick's fundraising events are held.the foundation also plays a leading role in working with others to advance more effective policies and increased federal funding for childhood cancer research. We work with coalitions of other nonprofits supportive of childhood cancer and jointly trained volunteer advocates to educate elected officials, legislative staff, and federal agencies as to the needs of children with cancer and the work of the researchers endeavoring to save them. The foundation is working with our partners to secure passage of the mikaela naylon give kids a chance act which will extend vital research incentives, ensure children with cancer continue to have access to the newest cures, and guarantee pediatric studies happen in a timely manner, and the accelerating kids' access to care act which will reduce red tape delays, allowing children with cancer and other complex medical needs who are covered by medicaid quicker access to time-sensitive care.

Financial Efficiency

• Mission deployment rate: 73.2%; rating input score 73
• Program expense ratio: 70.4%; rating input score 70
• Fundraising efficiency: $4.22 raised per $1 spent on fundraising; rating input score 17; 17th percentile among comparable filings

Transparency & Controls

• Consistency checks: 94.1%; rating input score 94; 20th percentile among comparable filings
• Pay-setting controls: 5 of 6 controls in place; rating input score 83
  • Compensation committee: Pass
  • Independent consultant: Missing
  • Other Form 990s reviewed: Pass
  • Written employment contract: Pass
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: 1 of 8 controls in place; rating input score 12
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Fail
  • Conducts field audits: Fail
  • May suspend future funding: Fail
  • Requires financial reports: Fail
  • Conducts site visits: Fail
  • Requires grant agreements: Fail
  • May require repayment: Fail
• Grant itemization coverage: 100%; rating input score 100; 72nd percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 93.8%; rating input score 94; 27th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -2.7%; rating input score 22; 22nd percentile among comparable filings
• Total-asset coverage ratio: 1.21; rating input score 43; 43rd percentile among comparable filings
• Liabilities to assets ratio: 0.62; rating input score 21; 21st percentile among comparable filings
• Officer compensation ratio: 6.1%; rating input score 42; 42nd percentile among comparable filings

Growth

• Program expense growth: -6.9% per year; rating input score 0; 3rd percentile among comparable filings
• Revenue growth: -5.9% per year; rating input score 0; 2nd percentile among comparable filings
• Asset growth: -7.5% per year; rating input score 0; 2nd percentile among comparable filings